Skip to main content
. 2014 Jan 21;62(2):213–221. doi: 10.1111/jgs.12660

Figure 2.

Figure 2

Cumulative incidence fatal and nonfatal coronary heart disease (CHD) and all-cause mortality depending on pravastatin treatment, stratified according to plasma homocysteine level at baseline. *P for multiplicative interaction = .21, †P for multiplicative interaction = .10.